Is Non-High-Density Lipoprotein Cholesterol a Marker and Therapeutic Target for Dyslipidemia in Metabolic Syndrome?

被引：0

作者：

Vega, Gloria Lena ^{[1
,2
,3
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dept Clin Nutr, Dallas, TX 75390 USA

[2] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA

[3] Vet Adm North Texas Hlth Care Syst, Dallas, TX USA

来源：

METABOLIC SYNDROME AND RELATED DISORDERS | 2014年 / 12卷 / 09期

关键词：

NON-HDL CHOLESTEROL; LIFE-STYLE INTERVENTION; CARDIOVASCULAR-DISEASE; RISK; APOLIPOPROTEINS; PREDICTOR; IDENTIFY; EVENTS; LIPIDS; MEN;

D O I：

10.1089/met.2014.1503

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：451 / 453

页数：3

共 17 条

[1]

[Anonymous], JAMA

[2] An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia [J].

Grundy, Scott M. ;

Arai, Hidenori ;

Barter, Philip ;

Bersot, Thomas P. ;

Betteridge, John ;

Carmena, Rafael ;

Cuevas, Ada ;

Davidson, Michael H. ;

Genest, Jacques ;

Kesaniemi, Y. Antero ;

Sadikot, Shaukat ;

Santos, Raul D. ;

Susekov, Andrey ;

Sy, Rody ;

Tokgozoglu, S. Lale ;

Watts, Gerald F. ;

Zhao, Dong .

JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (06) :561-565

[3] Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) [J].

Bittner, V ;

Hardison, R ;

Kelsey, SF ;

Weiner, BH ;

Jacobs, AK ;

Sopko, G .

CIRCULATION, 2002, 106 (20) :2537-2542

[4] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].

Boekholdt, S. Matthijs ;

Arsenault, Benoit J. ;

Mora, Samia ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Nestel, Paul J. ;

Simes, R. John ;

Durrington, Paul ;

Hitman, Graham A. ;

Welch, K. M. A. ;

DeMicco, David A. ;

Zwinderman, Aeilko H. ;

Clearfield, Michael B. ;

Downs, John R. ;

Tonkin, Andrew M. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Kastelein, John J. P. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309

[5] Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality [J].

Cui, YD ;

Blumenthal, RS ;

Flaws, JA ;

Whiteman, MK ;

Langenberg, P ;

Bachorik, PS ;

Bush, TL .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) :1413-1419

[6]

Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619

[7] Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes [J].

Jiang, R ;

Schulze, MB ;

Li, TC ;

Rifal, N ;

Stampfer, MJ ;

Rimm, EB ;

Hu, FB .

DIABETES CARE, 2004, 27 (08) :1991-1997

[8] Non-High-Density Lipoprotein Cholesterol Changes in Middle-Aged Obese Men With and Without Metabolic Syndrome During Weight Loss [J].

Kim, Maengkyu ;

Tanaka, Kiyoji .

METABOLIC SYNDROME AND RELATED DISORDERS, 2014, 12 (09) :464-471

[9]

Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512

[10] Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction [J].

Langsted, Anne ;

Freiberg, Jacob J. ;

Nordestgaard, Borge G. .

CIRCULATION, 2008, 118 (20) :2047-2056

← 1 2 →